Toggle navigation
Categories
Home
India
Latest News
Gujarat News
All India
World News
Latest World News
News in Hindi
News in Gujarati
All World News
Business News
India Business News
Stock Market News
Share Market Tips
News in Hindi
All Business News
Sports
Latest Sports News
Sports News in Hindi
All Sports
Entertainment
News in English
News in Hindi
All Entertainment
Health
World News
India News
All Health
Videos
Indian Food Recipes
Live News
Funny Video
Sadhguru - Yoga, Meditation & Spirituality
Yoga for Beginners – Daily Yoga Workout at Home
Informative Videos
Ayurvedic Upchar
All Videos
Music
BLOG
Home
/
1
India
/
1
Latest News
/
1
AstraZeneca#39;s Dapagliflozin gets DCGI nod for treatment of heart failure patients
1
AstraZeneca#39;s Dapagliflozin gets DCGI nod for treatment of heart failure patients
2020-7-4 08:30 pm
India
→
Latest News
41
0
0
The company has received import and market permission from DCGI in Form CT-20 (Marketing Authorisation- Additional Indication).
astrazeneca
dapagliflozin
treatment
heart
failure
patients
E-Mail
Facebook
LinkedIn
Twitter
Pinterest
VK
Prev
COVID-19 impact: As deals nosedive in student...
Next
This week in Auto: Indian EV startups beat...
You May Also Like
True grit | Paraplegic climbs up Hong Kong...
Norway probes 23 elderly patients' death after...
Rapid blood test identifies COVID-19 patients...
I thrived on the tension and drama of British...
Norway probes 23 elderly patients' death after...
Pandemic 'leads to slump in heart disease tests'
1
India vs Australia: टी. नटराजन बने भारत के लिए टेस्ट डेब्यू करने वाले 300वें खिलाड़ी
2
मैकग्रा को वर्ल्ड कप की इस गेंद के कारण आज भी पड़ती है भारत में गाली
3
सिर्फ 44 दिन में तीनों फॉर्मेट में डेब्यू कर नटराजन ने रचा इतिहास, वीरू ने यूं किया याद
4
Watch Live: President-Elect Biden Unveils $1.9 Trillion COVID Stimulus Plan
5
The Intercept Fires Co-Founder Who Publicly Discussed Reality Winner 'F*ck-Up'